Cargando…

The epidemic of acute lymphoid leukemia in China: current trends and future prediction

BACKGROUND: China has experienced one of the fastest increases in the incidence of acute lymphoid leukemia (ALL). The aim of this study was to assess the long-term trends of the incidence and mortality of ALL in mainland China between 1990 and 2019 and to project these trends through 2028. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Wenxuan, Liu, Shixuan, Shi, Ying, Tang, Qingyu, Sun, Jianzhong, Bai, Ruhai, Sun, Zhonghe, Du, Zhaoqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313194/
https://www.ncbi.nlm.nih.gov/pubmed/37397360
http://dx.doi.org/10.3389/fonc.2023.1195065
_version_ 1785067073528922112
author Zhu, Wenxuan
Liu, Shixuan
Shi, Ying
Tang, Qingyu
Sun, Jianzhong
Bai, Ruhai
Sun, Zhonghe
Du, Zhaoqing
author_facet Zhu, Wenxuan
Liu, Shixuan
Shi, Ying
Tang, Qingyu
Sun, Jianzhong
Bai, Ruhai
Sun, Zhonghe
Du, Zhaoqing
author_sort Zhu, Wenxuan
collection PubMed
description BACKGROUND: China has experienced one of the fastest increases in the incidence of acute lymphoid leukemia (ALL). The aim of this study was to assess the long-term trends of the incidence and mortality of ALL in mainland China between 1990 and 2019 and to project these trends through 2028. METHODS: Data on ALL were extracted from the Global Burden of Disease Study 2019; population data were extracted from World Population Prospects 2019. An age–period–cohort framework was used in the analysis. RESULTS: The net drift for the incidence of ALL was 7.5% (95% confidence interval [CI]: 7.1%, 7.8%) per year in women and 7.1% (95% CI: 6.7%, 7.6%) in men, and local drift was found to be higher than 0 in every studied age group (p<0.05). The net drift for mortality was 1.2% (95% CI: 1.0%, 1.5%) in women and 2.0% (95% CI: 1.7%, 2.3%) in men. Local drift was lower than 0 in boys aged 0–4 years and girls aged 0–9 years and higher than 0 in men aged 10–84 years and women aged 15–84 years. The estimated period relative risks (RRs) for both incidence and mortality showed increasing trends in the recent period. The cohort RRs for incidence showed increasing trends in both sexes; however, the cohort RR for mortality was decreased in the recent birth cohort (women born after 1988–1992 and men born after 2003–2007). Compared with that in 2019, the incidence of ALL in 2028 is projected to increase by 64.1% in men and 75.0% in women, and the mortality is predicted to decrease by 11.1% in men and 14.3% in women. The proportion of older adult/adults individuals with incident ALL and ALL-related death was projected to increase. CONCLUSIONS: Over the last three decades, the incidence and mortality rates of ALL have generally increased. It is projected that the incidence rate of ALL in mainland China will continue to increase in the future, but the associated mortality rate will decline. The proportion of older adult/adults individuals with incident ALL and ALL-related death was projected to increase gradually among both sexes. More efforts are needed, especially for older adult/adults individuals.
format Online
Article
Text
id pubmed-10313194
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103131942023-07-01 The epidemic of acute lymphoid leukemia in China: current trends and future prediction Zhu, Wenxuan Liu, Shixuan Shi, Ying Tang, Qingyu Sun, Jianzhong Bai, Ruhai Sun, Zhonghe Du, Zhaoqing Front Oncol Oncology BACKGROUND: China has experienced one of the fastest increases in the incidence of acute lymphoid leukemia (ALL). The aim of this study was to assess the long-term trends of the incidence and mortality of ALL in mainland China between 1990 and 2019 and to project these trends through 2028. METHODS: Data on ALL were extracted from the Global Burden of Disease Study 2019; population data were extracted from World Population Prospects 2019. An age–period–cohort framework was used in the analysis. RESULTS: The net drift for the incidence of ALL was 7.5% (95% confidence interval [CI]: 7.1%, 7.8%) per year in women and 7.1% (95% CI: 6.7%, 7.6%) in men, and local drift was found to be higher than 0 in every studied age group (p<0.05). The net drift for mortality was 1.2% (95% CI: 1.0%, 1.5%) in women and 2.0% (95% CI: 1.7%, 2.3%) in men. Local drift was lower than 0 in boys aged 0–4 years and girls aged 0–9 years and higher than 0 in men aged 10–84 years and women aged 15–84 years. The estimated period relative risks (RRs) for both incidence and mortality showed increasing trends in the recent period. The cohort RRs for incidence showed increasing trends in both sexes; however, the cohort RR for mortality was decreased in the recent birth cohort (women born after 1988–1992 and men born after 2003–2007). Compared with that in 2019, the incidence of ALL in 2028 is projected to increase by 64.1% in men and 75.0% in women, and the mortality is predicted to decrease by 11.1% in men and 14.3% in women. The proportion of older adult/adults individuals with incident ALL and ALL-related death was projected to increase. CONCLUSIONS: Over the last three decades, the incidence and mortality rates of ALL have generally increased. It is projected that the incidence rate of ALL in mainland China will continue to increase in the future, but the associated mortality rate will decline. The proportion of older adult/adults individuals with incident ALL and ALL-related death was projected to increase gradually among both sexes. More efforts are needed, especially for older adult/adults individuals. Frontiers Media S.A. 2023-06-16 /pmc/articles/PMC10313194/ /pubmed/37397360 http://dx.doi.org/10.3389/fonc.2023.1195065 Text en Copyright © 2023 Zhu, Liu, Shi, Tang, Sun, Bai, Sun and Du https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Zhu, Wenxuan
Liu, Shixuan
Shi, Ying
Tang, Qingyu
Sun, Jianzhong
Bai, Ruhai
Sun, Zhonghe
Du, Zhaoqing
The epidemic of acute lymphoid leukemia in China: current trends and future prediction
title The epidemic of acute lymphoid leukemia in China: current trends and future prediction
title_full The epidemic of acute lymphoid leukemia in China: current trends and future prediction
title_fullStr The epidemic of acute lymphoid leukemia in China: current trends and future prediction
title_full_unstemmed The epidemic of acute lymphoid leukemia in China: current trends and future prediction
title_short The epidemic of acute lymphoid leukemia in China: current trends and future prediction
title_sort epidemic of acute lymphoid leukemia in china: current trends and future prediction
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313194/
https://www.ncbi.nlm.nih.gov/pubmed/37397360
http://dx.doi.org/10.3389/fonc.2023.1195065
work_keys_str_mv AT zhuwenxuan theepidemicofacutelymphoidleukemiainchinacurrenttrendsandfutureprediction
AT liushixuan theepidemicofacutelymphoidleukemiainchinacurrenttrendsandfutureprediction
AT shiying theepidemicofacutelymphoidleukemiainchinacurrenttrendsandfutureprediction
AT tangqingyu theepidemicofacutelymphoidleukemiainchinacurrenttrendsandfutureprediction
AT sunjianzhong theepidemicofacutelymphoidleukemiainchinacurrenttrendsandfutureprediction
AT bairuhai theepidemicofacutelymphoidleukemiainchinacurrenttrendsandfutureprediction
AT sunzhonghe theepidemicofacutelymphoidleukemiainchinacurrenttrendsandfutureprediction
AT duzhaoqing theepidemicofacutelymphoidleukemiainchinacurrenttrendsandfutureprediction
AT zhuwenxuan epidemicofacutelymphoidleukemiainchinacurrenttrendsandfutureprediction
AT liushixuan epidemicofacutelymphoidleukemiainchinacurrenttrendsandfutureprediction
AT shiying epidemicofacutelymphoidleukemiainchinacurrenttrendsandfutureprediction
AT tangqingyu epidemicofacutelymphoidleukemiainchinacurrenttrendsandfutureprediction
AT sunjianzhong epidemicofacutelymphoidleukemiainchinacurrenttrendsandfutureprediction
AT bairuhai epidemicofacutelymphoidleukemiainchinacurrenttrendsandfutureprediction
AT sunzhonghe epidemicofacutelymphoidleukemiainchinacurrenttrendsandfutureprediction
AT duzhaoqing epidemicofacutelymphoidleukemiainchinacurrenttrendsandfutureprediction